Here's a summary of India Pesticides Limited's Q1 FY26 investor presentation: **1. Financial Highlights:** India Pesticides (IPL) posted robust Q1 FY26 results.

Revenue surged 25.8% YoY to ₹282 Cr.

EBITDA jumped 62.6% YoY to ₹52 Cr, with 18.4% margins, expected to stabilize.

PAT increased 79.2% YoY to ₹35 Cr.

Technicals & APIs comprised 71% of revenue, indicating strong core business performance. **2. Strategic Initiatives & Growth Drivers:** IPL significantly expanded its PEDA intermediate capacity, crucial for backward integration; further expansion is targeted by Q2 FY26. A ₹116 Cr capex is planned for FY26 to boost overall capacity.

Growth drivers include favorable monsoon outlook, export market recovery, new product registrations, and R&D focus. **3. Business Developments:** The successful commissioning of the expanded PEDA intermediate plant marks a significant development, enhancing supply chain resilience.

IPL is also broadening its global customer base by actively registering products in regulated markets, aiming to capture new opportunities. **4. Market Position & Competitive Advantage:** IPL is a leading Indian manufacturer of specific Thiocarbamate, Fungicide, and Herbicide Technicals, exporting to numerous countries.

Its competitive edge stems from robust in-house R&D capabilities, a diversified product portfolio, and long-standing relationships with multinational customers. **5. Investor Implications:** IPL's strong Q1 performance, coupled with strategic backward integration and planned capacity expansions, suggests positive growth potential.

Favorable market tailwinds and a consistent focus on operational efficiency position the company for sustained EBITDA growth and long-term value creation.